Etidronate down-regulates Toll-like receptor 2 ligand-induced chemokine production by inhibiting MyD88 expression and NF-κB activation

References

• Kim S, Seiryu M, Okada S, et al. Analgesic effects of the non-nitrogen-containing bisphosphonates etidronate and clodronate, independent of anti-resorptive effects on bone. Eur J Pharmacol. 2013;699(1-3):14–22.
   PubMed Web of Science ®Google Scholar
• Hayes KN, Ban JK, Athanasiadis G, et al. Time trends in oral bisphosphonate initiation in Ontario, Canada over 20 years reflect drug policy and healthcare delivery changes. Osteoporos Int. 2019;30(11):2311–2319.
   PubMed Web of Science ®Google Scholar
• Watts NB, Chesnut CH, 3rd, Genant HK, et al. History of etidronate. Bone. 2020;134:115222
   PubMed Web of Science ®Google Scholar
• Bauer C, Le Saux O, Pomozi V, et al. Etidronate prevents dystrophic cardiac calcification by inhibiting macrophage aggregation. Sci Rep. 2018;8(1):5812
   PubMedGoogle Scholar
• Dursun F, Atasoy OT, Guven S, et al. Magnesium and anti-phosphate treatment with bisphosphonates for generalised arterial calcification of infancy: a case report. J Clin Res Pediatr Endocrinol. 2019;11(3):311–318.
   PubMed Web of Science ®Google Scholar
• Zinnen SP, Karpeisky A, Von Hoff DD, et al. First-in-human phase I study of MBC-11, a novel bone-targeted cytarabine-etidronate conjugate in patients with cancer-induced bone disease. Oncologist. 2019;24(3):303–e102.
   PubMed Web of Science ®Google Scholar
• Bartstra JW, de Jong PA, Kranenburg G, et al. Etidronate halts systemic arterial calcification in pseudoxanthoma elasticum. Atherosclerosis. 2020;292:37–41.
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Yoshino S, Shue G, et al. Inhibitory effect of bone resorption and inflammation with etidronate therapy in patients with rheumatoid arthritis for 3 years and in vitro assay in arthritis models. Rheumatol Int. 2006;26(7):627–632.
   PubMed Web of Science ®Google Scholar
• Tamai R, Kiyoura Y. Alendronate augments lipid A-induced IL-1β release and Smad3/NLRP3/ASC-dependent cell death. Life Sci. 2018;198:8–17.
   PubMed Web of Science ®Google Scholar
• Moreau MF, Guillet C, Massin P, et al. Comparative effects of five bisphosphonates on apoptosis of macrophage cells in vitro. Biochem Pharmacol. 2007;73(5):718–723.
   PubMed Web of Science ®Google Scholar
• Malwal SR, O'Dowd B, Feng X, et al. Bisphosphonate-generated ATP-analogs inhibit cell signaling pathways. J Am Chem Soc. 2018;140(24):7568–7578.
   PubMed Web of Science ®Google Scholar
• Aida Y, Toda Y, Shimakoshi Y, et al. Effects of disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP) on interleukin 1 production by macrophages. Microbiol Immunol. 1986;30(11):1199–1206.
   PubMed Web of Science ®Google Scholar
• Olmos JM, De Vega T, Perera L, et al. Etidronate inhibits the production of IL-6 by osteoblast-like cells. Methods Find Exp Clin Pharmacol. 1999;21(8):519–522.
   PubMedGoogle Scholar
• Suzuki Y, Nishiyama T, Hasuda K, et al. Effect of etidronate on COX-2 expression and PGE(2) production in macrophage-like RAW 264.7 cells stimulated by titanium particles. J Orthop Sci. 2007;12(6):568–577.
   PubMed Web of Science ®Google Scholar
• Li W, Cheong YK, Wang H, et al. Neuroprotective effects of etidronate and 2,3,3-trisphosphonate against glutamate-induced toxicity in PC12 cells. Neurochem Res. 2016;41(4):844–854.
   PubMed Web of Science ®Google Scholar
• Hojo K, Tamai R, Kobayashi-Sakamoto M, et al. Etidronate down-regulates Toll-like receptor (TLR) 2 ligand-induced proinflammatory cytokine production by inhibiting NF-κB activation. Pharmacol Rep. 2017;69(4):773–778.
   PubMed Web of Science ®Google Scholar
• Tamai R, Suzuki K, Mashima I, et al. MPMBP down-regulates Toll-like receptor (TLR) 2 ligand-induced proinflammatory cytokine production by inhibiting NF-κB but not AP-1 activation. Int Immunopharmacol. 2020;79:106085
   PubMed Web of Science ®Google Scholar
• Yin ZY, Li L, Chu SS, et al. Antinociceptive effects of dehydrocorydaline in mouse models of inflammatory pain involve the opioid receptor and inflammatory cytokines. Sci Rep. 2016;6:27129
   PubMed Web of Science ®Google Scholar
• Nahrendorf M. Myeloid cell contributions to cardiovascular health and disease. Nat Med. 2018;24(6):711–720.
   PubMed Web of Science ®Google Scholar
• Tamai R, Kiyoura Y. Heat-killed Candida albicans augments synthetic bacterial component-induced proinflammatory cytokine production. Folia Microbiol (Praha). 2019;64(4):555–566.
   PubMed Web of Science ®Google Scholar
• Kawahara T, Nishikawa M, Kawahara C, et al. Atorvastatin, etidronate, or both in patients at high risk for atherosclerotic aortic plaques: a randomized, controlled trial. Circulation. 2013;127(23):2327–2335.
   PubMed Web of Science ®Google Scholar
• Shima K, Nemoto W, Tsuchiya M, et al. The bisphosphonates clodronate and etidronate exert analgesic effects by acting on glutamate- and/or ATP-related pain transmission pathways. Biol Pharm Bull. 2016;39(5):770–777.
   PubMed Web of Science ®Google Scholar
• Masuda T, Deng X, Tamai R. Mouse macrophages primed with alendronate down-regulate monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1alpha (MIP-1alpha) production in response to Toll-like receptor (TLR) 2 and TLR4 agonist via Smad3 activation. Int Immunopharmacol. 2009;9(9):1115–1121.
   PubMed Web of Science ®Google Scholar
• Gibson FC, 3rd, Hong C, Chou HH, et al. Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation. 2004;109(22):2801–2806.
   PubMed Web of Science ®Google Scholar
• Johansson L, Sherina N, Kharlamova N, et al. Concentration of antibodies against Porphyromonas gingivalis is increased before the onset of symptoms of rheumatoid arthritis. Arthritis Res Ther. 2016;18(1):201.
   PubMedGoogle Scholar
• Ji Y, Sun S, Shrestha N, et al. Toll-like receptors TLR2 and TLR4 block the replication of pancreatic β cells in diet-induced obesity. Nat Immunol. 2019;20(6):677–686.
   PubMed Web of Science ®Google Scholar
• Park SY, Lee SW, Lee WS, et al. RhoA/ROCK-dependent pathway is required for TLR2-mediated IL-23 production in human synovial macrophages: suppression by cilostazol. Biochem Pharmacol. 2013;86(9):1320–1327.
   PubMed Web of Science ®Google Scholar
• Saitoh S, Akashi S, Yamada T, et al. Lipid A antagonist, lipid IVa, is distinct from lipid A in interaction with Toll-like receptor 4 (TLR4)-MD-2 and ligand-induced TLR4 oligomerization. Int Immunol. 2004;16(7):961–969.
   PubMed Web of Science ®Google Scholar
• Tamai R, Sugamata M, Kiyoura Y. Amphotericin B up-regulates lipid A-induced IL-6 production via caspase-8. J Dent Res. 2012;91(7):709–714.
   PubMed Web of Science ®Google Scholar
• Akira S, Hoshino K. Myeloid differentiation factor 88-dependent and -independent pathways in Toll-like receptor signaling. J Infect Dis. 2003;187 (Suppl 2):S356–S363.
   PubMed Web of Science ®Google Scholar
• Cai S, Batra S, Shen L, et al. Both TRIF- and MyD88-dependent signaling contribute to host defense against pulmonary Klebsiella infection. J Immunol. 2009;183(10):6629–6638.
   PubMed Web of Science ®Google Scholar
• Mansson Kvarnhammar A, Tengroth L, Adner M, et al. Innate immune receptors in human airway smooth muscle cells: activation by TLR1/2, TLR3, TLR4, TLR7 and NOD1 agonists. PLoS One. 2013;8(7):e68701
   PubMed Web of Science ®Google Scholar
• Tamai R, Sugawara S, Takeuchi O, et al. Synergistic effects of lipopolysaccharide and interferon-γ in inducing interleukin-8 production in human monocytic THP-1 cells is accompanied by up-regulation of CD14, Toll-like receptor 4, MD-2 and MyD88 expression. J Endotoxin Res. 2003;9(3):145–153.
   PubMedGoogle Scholar
• Rajalakshmy AR, Malathi J, Madhavan HN. Hepatitis C virus NS3 mediated microglial inflammation via TLR2/TLR6 MyD88/NF-κB pathway and toll like receptor ligand treatment furnished immune tolerance. PLoS One. 2015;10(5):e0125419.
   PubMed Web of Science ®Google Scholar
• Smith PD, Shimamura M, Musgrove LC, et al. Cytomegalovirus enhances macrophage TLR expression and MyD88-mediated signal transduction to potentiate inducible inflammatory responses. J Immunol. 2014;193(11):5604–5612.
   PubMed Web of Science ®Google Scholar
• Park AM, Hagiwara S, Hsu DK, et al. Galectin-3 plays an important role in innate immunity to gastric infection by Helicobacter pylori. Infect Immun. 2016;84(4):1184–1193.
   PubMed Web of Science ®Google Scholar
• Andersen-Nissen E, Smith KD, Strobe KL, et al. Evasion of Toll-like receptor 5 by flagellated bacteria. Proc Natl Acad Sci USA. 2005;102(26):9247–9252.
   PubMed Web of Science ®Google Scholar
• Smith MF Jr., Mitchell A, Li G, et al. Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kappa B activation and chemokine expression by epithelial cells . J Biol Chem. 2003;278(35):32552–32560.
   PubMed Web of Science ®Google Scholar
• Tamai R, Sakuta T, Matsushita K, et al. Human gingival CD14(+) fibroblasts primed with gamma interferon increase production of interleukin-8 in response to lipopolysaccharide through up-regulation of membrane CD14 and MyD88 mRNA expression. Infect Immun. 2002;70(3):1272–1278.
   PubMed Web of Science ®Google Scholar
• Ogawa T, Asai Y, Makimura Y, et al. Chemical structure and immunobiological activity of Porphyromonas gingivalis lipid A. Front Biosci. 2007;12:3795–3812.
   PubMed Web of Science ®Google Scholar
• Yang CY, Lin CK, Lin GJ, et al. Triptolide represses oral cancer cell proliferation, invasion, migration, and angiogenesis in co-inoculation with U937 cells. Clin Oral Investig. 2017;21(1):419–427.
   PubMed Web of Science ®Google Scholar
• An J, Xue Y, Long M, et al. Targeting CCR2 with its antagonist suppresses viability, motility and invasion by downregulating MMP-9 expression in non-small cell lung cancer cells. Oncotarget. 2017;8(24):39230–39240.
   PubMedGoogle Scholar
• Casasanta MA, Yoo CC, Udayasuryan B, et al. Fusobacterium nucleatum host-cell binding and invasion induces IL-8 and CXCL1 secretion that drives colorectal cancer cell migration. Sci Signal. 2020;13(641):eaba9157.
   PubMed Web of Science ®Google Scholar
• Schalper KA, Carleton M, Zhou M, et al. Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors. Nat Med. 2020;26(5):688–692.
   PubMed Web of Science ®Google Scholar
• Yuen KC, Liu LF, Gupta V, et al. High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade. Nat Med. 2020;26(5):693–698.
   PubMed Web of Science ®Google Scholar
• Burns E, Bachrach G, Shapira L, et al. Cutting Edge: TLR2 is required for the innate response to Porphyromonas gingivalis: activation leads to bacterial persistence and TLR2 deficiency attenuates induced alveolar bone resorption. J Immunol. 2006;177(12):8296–8300.
   PubMed Web of Science ®Google Scholar
• Miyata N, Hayashi Y, Hayashi S, et al. Lipopolysaccharides from non-Helicobacter pylori gastric bacteria potently stimulate interleukin-8 production in gastric epithelial cells. Clin Transl Gastroenterol. 2019;10(3):e00024
   PubMedGoogle Scholar
• Buscetta M, Di Vincenzo S, Miele M, et al. Cigarette smoke inhibits the NLRP3 inflammasome and leads to caspase-1 activation via the TLR4-TRIF-caspase-8 axis in human macrophages. Faseb J. 2020;34(1):1819–1832.
   PubMed Web of Science ®Google Scholar
• Li L, Sun W, Wu T, et al. Caffeic acid phenethyl ester attenuates lipopolysaccharide-stimulated proinflammatory responses in human gingival fibroblasts via NF-κB and PI3K/Akt signaling pathway. Eur J Pharmacol. 2017;794:61–68.
   PubMed Web of Science ®Google Scholar
• Deng X, Tamai R, Endo Y, et al. Alendronate augments interleukin-1beta release from macrophages infected with periodontal pathogenic bacteria through activation of caspase-1. Toxicol Appl Pharmacol. 2009;235(1):97–104.
   PubMed Web of Science ®Google Scholar
• Makkonen N, Salminen A, Rogers MJ, et al. Contrasting effects of alendronate and clodronate on RAW 264 macrophages: the role of a bisphosphonate metabolite. Eur J Pharm Sci. 1999;8(2):109–118.
   PubMed Web of Science ®Google Scholar
• Tokuda H, Kozawa O, Harada A, et al. Tiludronate inhibits interleukin-6 synthesis in osteoblasts: inhibition of phospholipase D activation in MC3T3-E1 cells. J Cell Biochem. 1998;69(3):252–259.
   PubMed Web of Science ®Google Scholar
• Kato Y, Hiasa M, Ichikawa R, et al. Identification of a vesicular ATP release inhibitor for the treatment of neuropathic and inflammatory pain. Proc Natl Acad Sci USA. 2017;114(31):E6297–E6305.
   PubMed Web of Science ®Google Scholar
• Opperman KS, Vandyke K, Clark KC, et al. Clodronate-liposome mediated macrophage depletion abrogates multiple myeloma tumor establishment in vivo. Neoplasia. 2019;21(8):777–787.
   PubMed Web of Science ®Google Scholar
• Hajishengallis G, Wang M, Liang S. Induction of distinct TLR2-mediated proinflammatory and proadhesive signaling pathways in response to Porphyromonas gingivalis fimbriae. J Immunol. 2009;182(11):6690–6696.
   PubMed Web of Science ®Google Scholar
• Lee JH, Joo JH, Kim J, et al. Interaction of NADPH oxidase 1 with Toll-like receptor 2 induces migration of smooth muscle cells. Cardiovasc Res. 2013;99(3):483–493.
   PubMed Web of Science ®Google Scholar
• Li JM, Fan LM, Christie MR, et al. Acute tumor necrosis factor α signaling via NADPH oxidase in microvascular endothelial cells: role of p47phox phosphorylation and binding to TRAF4. MCB. 2005;25(6):2320–2330.
   PubMed Web of Science ®Google Scholar
• Cho RL, Yang CC, Tseng HC, et al. Haem oxygenase-1 up-regulation by rosiglitazone via ROS-dependent Nrf2-antioxidant response elements axis or PPARγ attenuates LPS-mediated lung inflammation. Br J Pharmacol. 2018;175(20):3928–3946.
   PubMed Web of Science ®Google Scholar